These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32785927)

  • 21. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
    Syn NL; Yong WP; Goh BC; Lee SC
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Importance of Cancer Stem Cells in Gastrointestinal Cancers.
    Dindar DA; Albayrak G; Ozet A
    Crit Rev Oncog; 2019; 24(1):55-59. PubMed ID: 31679220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Old Tyrosine Kinase Inhibitors and Newcomers in Gastrointestinal Cancer Treatment.
    Giordani E; Zoratto F; Strudel M; Papa A; Rossi L; Minozzi M; Caruso D; Zaccarelli E; Verrico M; Tomao S
    Curr Cancer Drug Targets; 2016; 16(2):175-85. PubMed ID: 26278713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Precision Oncology in Gastrointestinal and Colorectal Cancer Surgery.
    McDonald HG; Kerekes DM; Kim J; Khan SA
    Surg Oncol Clin N Am; 2024 Apr; 33(2):321-341. PubMed ID: 38401913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers.
    Hogenson TL; Xie H; Phillips WJ; Toruner MD; Li JJ; Horn IP; Kennedy DJ; Almada LL; Marks DL; Carr RM; Toruner M; Sigafoos AN; Koenig-Kappes AN; Olson RL; Tolosa EJ; Zhang C; Li H; Doles JD; Bleeker J; Barrett MT; Boyum JH; Kipp BR; Mahipal A; Hubbard JM; Scheffler Hanson TJ; Petersen GM; Dasari S; Oberg AL; Truty MJ; Graham RP; Levy MJ; Zhu M; Billadeau DD; Adjei AA; Dusetti N; Iovanna JL; Bekaii-Saab TS; Ma WW; Fernandez-Zapico ME
    JCI Insight; 2022 Nov; 7(22):. PubMed ID: 36256477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational Testing in Gastrointestinal Stromal Tumor.
    Wang Y; Call J
    Curr Cancer Drug Targets; 2019; 19(9):688-697. PubMed ID: 30914028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers Part 1: GI carcinomas.
    Neuzillet C; Rousseau B; Kocher H; Bourget P; Tournigand C
    Pharmacol Ther; 2017 Jun; 174():145-172. PubMed ID: 28223233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 17th World Congress on Gastrointestinal Cancers.
    Brierley R
    Lancet Oncol; 2015 Aug; 16(8):890. PubMed ID: 26163153
    [No Abstract]   [Full Text] [Related]  

  • 29. The Role of Target Therapy in the Treatment of Gastrointestinal Noncolorectal Cancers: Clinical Impact and Cost Consideration.
    Berretta M; Romano C; Di Francia R; De Diviitis C; Canzonieri V; Caraglia M; Facchini G; Nasti G
    Curr Cancer Drug Targets; 2018; 18(5):430-441. PubMed ID: 28183250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [NEW ERA OF PERSONALIZED MEDICINE THROUGH NEXT－GENERATION SEQUENCING].
    Furukawa Y
    Nihon Geka Gakkai Zasshi; 2016 Nov; 117(6):530-5. PubMed ID: 30173479
    [No Abstract]   [Full Text] [Related]  

  • 31. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
    Blumenthal GM; Mansfield E; Pazdur R
    JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
    [No Abstract]   [Full Text] [Related]  

  • 32. The New Era in Lung Cancer Care.
    Oncology (Williston Park); 2020 Aug; 34(8):302-304. PubMed ID: 32785923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
    Coyne GO; Takebe N; Chen AP
    Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomics-Enabled Precision Medicine for Cancer.
    Roos A; Byron SA
    Cancer Treat Res; 2019; 178():137-169. PubMed ID: 31209844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted molecular therapy for cancer: the application of STI571 to gastrointestinal stromal tumor.
    Dematteo RP; Maki RG; Antonescu C; Brennan MF
    Curr Probl Surg; 2003 Mar; 40(3):144-93. PubMed ID: 12571542
    [No Abstract]   [Full Text] [Related]  

  • 36. Targeted therapies in upper gastrointestinal malignancies.
    Azzariti A; Silvestris N
    Curr Med Chem; 2014; 21(8):947. PubMed ID: 23992326
    [No Abstract]   [Full Text] [Related]  

  • 37. Targeted molecular ablation of cancer stem cells for curing gastrointestinal cancers.
    Kim YS; Lee HJ; Park JM; Han YM; Kangwan N; Oh JY; Lee DY; Hahm KB
    Expert Rev Gastroenterol Hepatol; 2017 Nov; 11(11):1059-1070. PubMed ID: 28707966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New therapeutic agents in gastrointestinal stromal tumours.
    Falkenhorst J; Hamacher R; Bauer S
    Curr Opin Oncol; 2019 Jul; 31(4):322-328. PubMed ID: 31033566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aquaporins: Their role in gastrointestinal malignancies.
    Nagaraju GP; Basha R; Rajitha B; Alese OB; Alam A; Pattnaik S; El-Rayes B
    Cancer Lett; 2016 Apr; 373(1):12-18. PubMed ID: 26780474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Precision medicine for advanced prostate cancer.
    Mullane SA; Van Allen EM
    Curr Opin Urol; 2016 May; 26(3):231-9. PubMed ID: 26909474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.